You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Baseline patient characteristics

From: Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding

patient age (years); median (range) 71 (45-84)
planning target volume (cm3); median (range) 336 (169-631)
PSA (ng/ml); median (range) ≤10 ng/ml; n (%) 8 (1.2-150) 178 (62)
biopsy Gleason score <7; n (%) 185 (65)
clinical T-stage ≤2a; n (%) 237 (83)
low risk (PSA≤10 ng/ml; Gleason score <7; clinical T-stage ≤2a); n (%) 106 (37)
intermediate risk (PSA 10-20 ng/ml or Gleason score = 7 or clinical T-stage 2b-c); n (%) 101 (35)
high risk (two risk factors or PSA>20 ng/ml or Gleason score >7 or clinical T-stage >2c); n (%) 79 (28)
neoadjuvant hormonal therapy; n (%) 90 (32)
any documented comorbidity;; n (%) 179 (63)
hypertension; n (%) 74 (26)
coronary heart disease; n (%) 76 (27)
diabetes; n (%) 34 (12)
chronic obstructive pulmonary disease; n (%) 31 (11)
haemorrhoids; n (%) 17 (6)
stroke in past history; n (%) 12 (4)
peripheral arterial disease; n (%) 10 (4)
chronic renal failure; n (%) 8 (3)